108
Participants
Start Date
August 19, 2019
Primary Completion Date
August 22, 2022
Study Completion Date
September 28, 2022
Ad26.ZEBOV
Participants will receive 0.5 mL IM injection of Ad26.ZEBOV as first vaccination.
MVA-BN-Filo
Participants will receive 0.5 mL IM injection of MVA-BN-Filo as second vaccination.
MenACWY
Participants will receive 0.5 mL IM injection of MenACWY.
Centre National de Formation et de Recherche en Sante Rurale de Maferinyah, Conakry
College of Med and Allied Health Sciences, University of Sierra Leone, Freetown
London School of Hygiene and Tropical Medicine
OTHER
University of Sierra Leone
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Janssen Vaccines & Prevention B.V.
INDUSTRY